Azevan Pharmaceuticals, Inc.

Azevan Pharmaceuticals, Inc. (Azevan or the Company) is developing novel therapeutics for the treatment of disorders of stress, mood, and behavior. The Company leverages its expertise in behavioral neurobiology with its proprietary chemistry platform targeting G-protein coupled receptors (GPCRs) to create drug candidates. Azevan’s first series of clinical candidates selectively block the effects of arginine vasopressin (AVP), which is involved in the pathophysiology of various conditions including stress-related affective illness, impulsivity/inappropriate aggression, and menstrual-related disorders.
The value proposition for Azevan lies in its strong preclinical pipeline, the diverse indications and significant potential markets for selective vasopressin antagonists, and the flexibility of its proprietary chemistry that allows targeting of additional high value G-protein coupled receptors.

Contact Details: 115 Research Drive Bethlehem Pennsylvania 18015 United States of America Tel: (610) 419 1057 Fax: (610) 861 8247 Email: WWW: www.azevan.com/

Loading...

BioNews Results for Azevan Pharmaceuticals, Inc.:
Barr Receives Approval for Generic Version of Razadyne(R) Tablets	Montana's News Station:  Aug 31 2008 2:04PM Matching: pharmaceuticals inc
King Pharmaceuticals (NYSE:KG) Has Agreed To Settle Also The Shareholder Derivative Lawsuit	PR inside:  Aug 31 2008 6:36AM Matching: pharmaceuticals inc
Barr Receives Approval for Generic Version of Razadyne(R) Tablets	KSLA:  Aug 30 2008 3:44PM Matching: pharmaceuticals inc
Barr Receives Approval for Generic Version of Razadyne(R) Tablets	KRON4:  Aug 30 2008 11:18AM Matching: pharmaceuticals inc
Beacon Equity Issues Technical Trade Alerts on: CEGE, AMLN, DNA, GENZ, AMGN, GILD	TransWorldNews:  Aug 30 2008 4:56PM Matching: pharmaceuticals inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more Azevan Pharmaceuticals, Inc. news.

Azevan Pharmaceuticals, Inc. Patents:
US Patent No.	Title
7268125	.beta.-lactamyl vasopressin V.sub.1a antagonists
7119083	.beta.-Lactamyl vasopressin V.sub.1a Antagonists

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 296 times since April 2007, the link to the organisation's website has been followed 41 times

Recent Search Terms used to find this page: azevan patent | t | Azevan Pharmaceuticals Inc. | azevan pharmaceuticals inc. | Azevan | Azevan Pharmaceuticals | azevan | t | azevan | azevan | .

Search for more companies in Bethlehem

Search for more companies in Pennsylvania

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Azevan Pharmaceuticals, Inc.